Veradermics, Incorporated (MANE) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Veradermics, Incorporated reported total assets of $152.62M and total liabilities of $273.63M. Shareholders' equity was negative at −$121.01M, meaning liabilities exceed assets. Total debt stood at $4.00K against $141.86M in cash and short-term investments, a net cash position of $141.86M.

Veradermics, Incorporated Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Veradermics, Incorporated (MANE) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023
Period ending	Dec 2025	Dec 2024	Dec 2023
Current Assets
Cash and Cash Equivalents	21.77	53.08	16.30
Short-Term Investments	120.10	0.00	0.00
Cash & Short-Term Investments	141.86	53.08	16.30
Accounts Receivable	1.26	1.38	0.00
Inventory	0.00	0.00	0.00
Other Current Assets	0.38	1.08	0.05
Total Current Assets	152.49	55.54	17.56
Non-Current Assets
Property, Plant & Equipment (Net)	0.13	0.00	0.00
Long-Term Investments	0.00	3.85	0.89
Other Non-Current Assets	0.00	0.00	0.00
Total Non-Current Assets	0.13	3.85	0.89
Total Assets	152.62	59.38	17.56
Current Liabilities
Accounts Payable	2.13	2.25	1.85
Accrued Liabilities	6.98	2.47	1.20
Other Current Liabilities	0.05	2.47	1.20
Total Current Liabilities	9.15	4.72	3.05
Non-Current Liabilities
Long-Term Debt	0.00	0.00	0.79
Other Non-Current Liabilities	264.48	0.00	0.00
Total Non-Current Liabilities	264.48	0.00	36.75
Total Liabilities	273.63	4.72	39.80
Stockholders' Equity
Common Stock	0.00	0.00	0.00
Retained Earnings	-123.42	-49.23	-22.74
Accumulated Other Comprehensive Income	0.06	0.00	0.00
Additional Paid-in Capital	2.35	0.75	0.50
Shares Outstanding	37.34	35.08	35.08
Total Stockholders' Equity	-121.01	54.67	-22.24
Total Liabilities & Equity	152.62	59.38	17.56

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Veradermics, Incorporated Balance Sheet

How much debt does Veradermics, Incorporated have?

Veradermics, Incorporated had total debt of $4.00K as of Dec 31, 2025, against $141.86M in cash and short-term investments. Total debt was $0.00 a year earlier.

What are Veradermics, Incorporated's total assets?

Veradermics, Incorporated reported total assets of $152.62M as of Dec 31, 2025, up 157.0% from $59.38M a year earlier. Total liabilities were $273.63M.

What is Veradermics, Incorporated's shareholders' equity?

Veradermics, Incorporated's shareholders' equity was negative at −$121.01M as of Dec 31, 2025, so its liabilities exceeded its assets.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition